Haploinsufficiency of CBFA2 causes familial thrombocytopenia with propensity to develop acute myelogenous leukaemia

Familial platelet disorder with predisposition to acute myelogenous leukaemia (FPD/AML, MIM 601399) is an autosomal dominant disorder characterized by qualitative and quantitative platelet defects, and propensity to develop acute myelogenous leukaemia (AML). Informative recombination events in 6 FPD/AML pedigrees with evidence of linkage to markers on chromosome 21q identified an 880-kb interval containing the disease gene. Mutational analysis of regional candidate genes showed nonsense mutations or intragenic deletion of one allele of the haematopoietic transcription factor CBFA2 (formerly AML1) that co-segregated with the disease in four FPD/AML pedigrees. We identified heterozygous CBFA2 missense mutations that co-segregated with the disease in the remaining two FPD/AML pedigrees at phylogenetically conserved amino acids R166 and R201, respectively. Analysis of bone marrow or peripheral blood cells from affected FPD/AML individuals showed a decrement in megakaryocyte colony formation, demonstrating that CBFA2 dosage affects megakaryopoiesis. Our findings support a model for FPD/AML in which haploinsufficiency of CBFA2 causes an autosomal dominant congenital platelet defect and predisposes to the acquisition of additional mutations that cause leukaemia.

[1]  Y. Fujiwara,et al.  FOG-2: A novel GATA-family cofactor related to multitype zinc-finger proteins Friend of GATA-1 and U-shaped. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[2]  T. Golub,et al.  The t(12;21) translocation converts AML-1B from an activator to a repressor of transcription , 1996, Molecular and cellular biology.

[3]  K. Shigesada,et al.  A simple screening for mutant DNA binding proteins: application to murine transcription factor PEBP2alpha subunit, a founding member of the Runt domain protein family. , 1997, Gene.

[4]  M. Ohki,et al.  The t(8;21) translocation in acute myeloid leukemia results in production of an AML1‐MTG8 fusion transcript. , 1993, The EMBO journal.

[5]  Christine Chomienne,et al.  The t(15;17) translocation of acute promyelocytic leukaemia fuses the retinoic acid receptor α gene to a novel transcribed locus , 1990, Nature.

[6]  M. Marín‐Padilla,et al.  Disruption of the Cbfa2 gene causes necrosis and hemorrhaging in the central nervous system and blocks definitive hematopoiesis. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[7]  M. Leppert,et al.  Linkage of a familial platelet disorder with a propensity to develop myeloid malignancies to human chromosome 21q22.1-22.2. , 1996, Blood.

[8]  R. Weinberg,et al.  Oncogenes, antioncogenes, and the molecular bases of multistep carcinogenesis. , 1989, Cancer research.

[9]  J. Downing,et al.  AML1, the Target of Multiple Chromosomal Translocations in Human Leukemia, Is Essential for Normal Fetal Liver Hematopoiesis , 1996, Cell.

[10]  T. Golub,et al.  Incidence of TEL/AML1 fusion in children with relapsed acute lymphoblastic leukemia. , 1998, Blood.

[11]  F. Collins,et al.  Fusion between transcription factor CBF beta/PEBP2 beta and a myosin heavy chain in acute myeloid leukemia. , 1993, Science.

[12]  M. Ratajczak,et al.  Megakaryocyte precursors, megakaryocytes and platelets express the HIV co‐receptor CXCR4 on their surface: determination of response to stromal‐derived factor‐1 by megakaryocytes and platelets , 1999, British journal of haematology.

[13]  I. Bar-Am,et al.  A large variety of alternatively spliced and differentially expressed mRNAs are encoded by the human acute myeloid leukemia gene AML1. , 1996, DNA and cell biology.

[14]  J. Rowley,et al.  Rearrangement of the MLL gene in acute lymphoblastic and acute myeloid leukemias with 11q23 chromosomal translocations. , 1993, The New England journal of medicine.

[15]  H. Hirai,et al.  An acute myeloid leukemia gene, AML1, regulates hemopoietic myeloid cell differentiation and transcriptional activation antagonistically by two alternative spliced forms. , 1995, The EMBO journal.

[16]  Todd R. Golub,et al.  Fusion of PDGF receptor β to a novel ets-like gene, tel, in chronic myelomonocytic leukemia with t(5;12) chromosomal translocation , 1994, Cell.

[17]  J. Bushweller,et al.  Biochemical and Biophysical Properties of the Core-binding Factor α2 (AML1) DNA-binding Domain* , 1996, The Journal of Biological Chemistry.

[18]  E. Macintyre,et al.  High frequency of t(12;21) in childhood B-lineage acute lymphoblastic leukemia. , 1995, Blood.

[19]  R I Richards,et al.  Genetic heterogeneity in familial acute myelogenous leukemia: evidence for a second locus at chromosome 16q21-23.2. , 1997, American journal of human genetics.

[20]  H. Drabkin,et al.  Identification of breakpoints in t(8;21) acute myelogenous leukemia and isolation of a fusion transcript, AML1/ETO, with similarity to Drosophila segmentation gene, runt. , 1992, Blood.

[21]  M. Ratajczak,et al.  In vitro and in vivo evidence that ex vivo cytokine priming of donor marrow cells may ameliorate posttransplant thrombocytopenia. , 1998, Blood.

[22]  J. Rowley,et al.  The critical role of chromosome translocations in human leukemias. , 1998, Annual review of genetics.

[23]  B. Vogelstein,et al.  Differentiation of leukemia cells to polymorphonuclear leukocytes in patients with acute nonlymphocytic leukemia. , 1986, The New England journal of medicine.

[24]  D. Jamison,et al.  Studies of a familial platelet disorder , 1985 .

[25]  D. Gilliland,et al.  CBFA2, frequently rearranged in leukemia, is not responsible for a familial leukemia syndrome , 1997, Leukemia.

[26]  U. Francke,et al.  A serine/proline-rich protein is fused to HRX in t(4;11) acute leukemias. , 1993, Blood.

[27]  D. Linch,et al.  Tissue specificity of X-chromosome inactivation patterns. , 1994, Blood.

[28]  Chaohong Sun,et al.  The Ig fold of the core binding factor alpha Runt domain is a member of a family of structurally and functionally related Ig-fold DNA-binding domains. , 1999, Structure.

[29]  Y. Kwong,et al.  Evidence for Genetic Homogeneity in a Familial Platelet Disorder With Predisposition to Acute Myelogenous Leukemia ( FPD / AML ) , 1998 .

[30]  D. Le Paslier,et al.  The t(12;21) of acute lymphoblastic leukemia results in a tel-AML1 gene fusion. , 1995, Blood.

[31]  James M. Roberts,et al.  The murine gene p27Kip1 is haplo-insufficient for tumour suppression , 1998, Nature.

[32]  N. Copeland,et al.  PEBP2 alpha B/mouse AML1 consists of multiple isoforms that possess differential transactivation potentials , 1994, Molecular and cellular biology.

[33]  S. Orkin,et al.  Transcription factor NF-E2 is required for platelet formation independent of the actions of thrombopoeitin/MGDF in megakaryocyte development , 1995, Cell.

[34]  J. Downing,et al.  Low frequency of TEL-AML1 in relapsed acute lymphoblastic leukemia supports a favorable prognosis for this genetic subgroup , 1999, Leukemia.

[35]  D. Gilliland,et al.  Clonal evolution in acute myeloid leukemia [editorial; comment] , 1993 .

[36]  H. Yamasaki,et al.  Biallelic and heterozygous point mutations in the runt domain of the AML1/PEBP2alphaB gene associated with myeloblastic leukemias. , 1999, Blood.

[37]  S. Orkin,et al.  A lineage‐selective knockout establishes the critical role of transcription factor GATA‐1 in megakaryocyte growth and platelet development , 1997, The EMBO journal.

[38]  T. Gu,et al.  Core-binding factor: a central player in hematopoiesis and leukemia. , 1999, Cancer research.

[39]  N. Lenny,et al.  The t(8;21) fusion protein interferes with AML-1B-dependent transcriptional activation , 1995, Molecular and cellular biology.

[40]  M. Wasik,et al.  Effect of hepatocyte growth factor on early human haemopoietic cell development , 1997, British journal of haematology.

[41]  P. Nowell,et al.  Genes on chromosomes 4, 9, and 19 involved in 11q23 abnormalities in acute leukemia share sequence homology and/or common motifs. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[42]  A. Knudson.  Karnofsky Memorial Lecture. Hereditary cancer: theme and variations. , 1997, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[43]  M. Freedman,et al.  Fusion Between Transcription Factor CBFP/PEBP2I3 andaMyosin HeavyChain in AcuteMyeloid Leukemia , 1993 .

[44]  D C Ward,et al.  Fusion of the TEL gene on 12p13 to the AML1 gene on 21q22 in acute lymphoblastic leukemia. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[45]  Yoshiaki Ito,et al.  Functional Dissection of the α and β Subunits of Transcription Factor PEBP2 and the Redox Susceptibility of Its DNA Binding Activity* , 1996, The Journal of Biological Chemistry.

[46]  Joseph Haydn,et al.  Theme and variations , 1956 .

[47]  S. Israels,et al.  Inherited platelet‐storage pool deficiency associated with a high incidence of acute myeloid leukaemia , 1991, British journal of haematology.

[48]  J. Rowley.  Seminars from the University of Minnesota. Chromosome translocations: dangerous liaisons. , 1998, The Journal of laboratory and clinical medicine.

[49]  J. Rowley.  Chromosome translocations: Dangerous liaisons , 1998 .

[50]  C. Wijmenga,et al.  Failure of Embryonic Hematopoiesis andLethal Hemorrhages in Mouse Embryos Heterozygousfor a Knocked-In Leukemia Gene CBFB–MYH11 , 1996, Cell.

[51]  M. Marín‐Padilla,et al.  Embryonic lethality and impairment of haematopoiesis in mice heterozygous for an AML1-ETO fusion gene , 1997, Nature Genetics.

[52]  J. Downing,et al.  Expression of a knocked-in AML1-ETO leukemia gene inhibits the establishment of normal definitive hematopoiesis and directly generates dysplastic hematopoietic progenitors. , 1998, Blood.